Revolution Medicines, Inc.

Revolution Medicines, Inc.verified

RVMD

Price:

$43.93

Market Cap:

$8.01B

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RA...[Read more]

Industry

Biotechnology

IPO Date

2020-02-13

Stock Exchange

NASDAQ

Ticker

RVMD

The Enterprise Value as of December 2024 (TTM) for Revolution Medicines, Inc. (RVMD) is 7.90B

According to Revolution Medicines, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.90B. This represents a change of 43.22% compared to the average of 5.51B of the last 4 quarters.

Revolution Medicines, Inc. (RVMD) Historical Enterprise Value (quarterly & annually)

How has RVMD Enterprise Value performed in the past?

The mean historical Enterprise Value of Revolution Medicines, Inc. over the last ten years is 1.79B. The current 7.90B Enterprise Value has changed 44.00% with respect to the historical average. Over the past ten years (40 quarters), RVMD's Enterprise Value was at its highest in in the September 2024 quarter at 7.45B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

1.79B

Median

1.79B

Minimum

984.63M

Maximum

2.64B

Revolution Medicines, Inc. (RVMD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Revolution Medicines, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 71.50%

Maximum Annual Enterprise Value = 2.64B

Minimum Annual Increase = -30.19%

Minimum Annual Enterprise Value = 984.63M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20232.64B44.62%
20221.82B1.82%
20211.79B-30.19%
20202.57B51.90%
20191.69B71.50%
2018984.63M-5.78%

Revolution Medicines, Inc. (RVMD) Average Enterprise Value

How has RVMD Enterprise Value performed in the past?

The current Enterprise Value of Revolution Medicines, Inc. (RVMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

2.08B

5-year avg

2.10B

10-year avg

1.79B

Revolution Medicines, Inc. (RVMD) Enterprise Value vs. Peers

How is RVMD’s Enterprise Value compared to its peers?

Revolution Medicines, Inc.’s Enterprise Value is greater than Blueprint Medicines Corporation (6.12B), greater than Sana Biotechnology, Inc. (333.02M), greater than Kymera Therapeutics, Inc. (2.62B), greater than Monte Rosa Therapeutics, Inc. (356.78M), greater than TCR2 Therapeutics Inc. (79.12M), greater than Black Diamond Therapeutics, Inc. (123.50M), greater than Atreca, Inc. (-8620212.00), greater than Passage Bio, Inc. (33.56M), greater than Akero Therapeutics, Inc. (1.70B), greater than Avidity Biosciences, Inc. (3.41B), greater than Protagonist Therapeutics, Inc. (2.30B), greater than Stoke Therapeutics, Inc. (467.23M), greater than Homology Medicines, Inc. (-103303255.00), greater than C4 Therapeutics, Inc. (294.04M), greater than Agios Pharmaceuticals, Inc. (1.82B), greater than Nurix Therapeutics, Inc. (1.34B),

Build a custom stock screener for Revolution Medicines, Inc. (RVMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revolution Medicines, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Revolution Medicines, Inc. (RVMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Revolution Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Revolution Medicines, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Revolution Medicines, Inc. (RVMD)?

What is the 3-year average Enterprise Value for Revolution Medicines, Inc. (RVMD)?

What is the 5-year average Enterprise Value for Revolution Medicines, Inc. (RVMD)?

How does the current Enterprise Value for Revolution Medicines, Inc. (RVMD) compare to its historical average?